2025-04-03 - Analysis Report
## Natera Inc. (NTRA) Stock Review

**0. Summary of Key Figures:**

* **Cumulative Return (NTRA):** 372.82%
* **Cumulative Return (VOO):** 89.44%
* **Return Difference:** 283.38%
* **Relative Divergence:** 43.6% (Indicates NTRA's performance is significantly higher than VOO, relative to its historical volatility against VOO)
* **Current Price:** $140.65
* **Market Risk Indicator (MRI):** 0.4354 (Medium Risk)


**1. Performance Comparison & Company Overview:**

Natera Inc. is a company focused on developing and commercializing genetic testing and diagnostics.  NTRA's cumulative return significantly outperforms the S&P 500 (VOO) by 283.38%.  While its relative divergence of 43.6% suggests strong performance relative to its historical fluctuations against VOO, it's crucial to remember this doesn't guarantee future outperformance.

The provided CAGR data shows highly volatile growth with periods of significant gains and losses.  Beta values fluctuate widely, indicating varying sensitivity to market movements over time.  High Beta values during periods of high CAGR suggests the company's performance is highly leveraged to market trends.  The negative CAGR in 2021-2023 highlights a significant downturn.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | -13.0% | 25.7% | -31.0% | 0.1 | 1.2 |
| 2016-2018  | 51.0% | 54.0% | 44.0% | 0.0 | 1.9 |
| 2017-2019  | 181.0% | 54.0% | 162.0% | 0.4 | 4.7 |
| 2018-2020  | 601.0% | 54.0% | 567.0% | 0.2 | 13.8 |
| 2019-2021  | 450.0% | 28.0% | 377.0% | 0.2 | 12.9 |
| 2020-2022  | -96.0% | 55.8% | -107.0% | 0.2 | 5.6 |
| 2021-2023  | -481.0% | 55.8% | -499.0% | 0.9 | 8.7 |
| 2022-2024  | 106.0% | 55.8% | 84.0% | 0.8 | 21.9 |
| 2023-2025  | 282.0% | 53.1% | 242.0% | 0.7 | 19.5 |


**2. Recent Price Movement:**

* **Closing Price:** $140.65
* **Last Market Price:** $144.37 (a 2.64 increase from the previous close)
* **5-Day Moving Average:** $144.83
* **20-Day Moving Average:** $145.88
* **60-Day Moving Average:** $160.40

The price is currently below all three moving averages, suggesting a potential downward trend in the short term.  The recent price increase of $2.64 indicates a possible short-term recovery, but further observation is needed.

**3. Technical Indicators & Expected Return:**

* **MRI:** 0.4354 (Medium Risk) indicating moderate market volatility.
* **RSI:** 44.71 (Slightly below 50, suggesting a slightly bearish trend)
* **PPO:** -0.0131 (Negative, indicating bearish momentum)
* **Relative Divergence Change (20-day):** -6.2% (Short-term downward trend)
* **Expected Return (2+ years):** 136.1% (Significant outperformance of the S&P 500 is expected over the long term, but this projection needs to be considered cautiously given its high volatility).  The recent price jump suggests a potential short-term reversal, but the overall trend might be affected by this.


**4. Recent Earnings Analysis:**

The company is currently reporting losses. Revenue is growing, but EPS is consistently negative, indicating profitability concerns.  Further investigation into the reasons behind the losses is required.

| Date       | EPS   | Revenue      |
|------------|-------|--------------|
| 2024-11-12 | -0.26 | $0.44 B      |
| 2024-08-09 | -0.3  | $0.41 B      |
| 2024-05-10 | -0.56 | $0.37 B      |
| 2023-11-09 | -0.95 | $0.27 B      |
| 2024-11-12 | -0.95 | $0.27 B      |


**5. Financial Information:**

Revenue is consistently increasing, indicating growth. Profit margins are also high and increasing, but the negative ROE indicates that the company may not be generating sufficient returns on its equity investment.  This requires further investigation into the balance sheet and the use of capital.

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $0.48B | 62.94%       |
| 2024-09-30 | $0.44B | 61.79%       |
| 2024-06-30 | $0.41B | 58.83%       |
| 2024-03-31 | $0.37B | 56.72%       |
| 2023-12-31 | $0.31B | 51.38%       |


**Capital and Profitability:**

| Quarter | Equity | ROE    |
|---------|---------|--------|
| 2024-12-31 | $1.20B | -4.50% |
| 2024-09-30 | $0.88B | -3.60% |
| 2024-06-30 | $0.84B | -4.48% |
| 2024-03-31 | $0.79B | -8.51% |
| 2023-12-31 | $0.77B | -10.20%|


**6. Overall Analysis:**

NTRA shows significant potential for high returns, but also carries substantial risk. The extremely volatile historical performance, coupled with currently negative EPS despite growing revenue, demands careful consideration. While the long-term expected return is attractive, the high beta and negative ROE raise concerns about sustainability.  Further due diligence, including a thorough examination of the company's financial statements, business model, and competitive landscape, is necessary before making any investment decision.  The recent price jump should be interpreted cautiously and requires monitoring to determine if it's a sustained reversal or a temporary fluctuation.  The high profit margin is a positive, but the negative ROE needs explanation.
